Global Tildrakizumab market size is expected to reach $3.02 billion by 2030 at 11.4%, rising prevalence of psoriasis boosts growth of the market
Read MoreGlobal Tick Borne Encephalitis market size is expected to reach $15.09 billion by 2030 at 7.4%, rising global temperatures driving the growth of the market due to expanding tick habitats
Read MoreThyroid Function Test market size is expected to reach $2.41 billion by 2030 at 5.7%, driven by rising prevalence of thyroid disorders.
Read MoreGlobal Thyroid Eye Disease (TED) market size is expected to reach $3.12 billion by 2030 at 6.3%, thyroid disorders and their influence on the market dynamics
Read MoreGlobal Thyroid Cancer Diagnostics market size is expected to reach $4.25 billion by 2030 at 6.2%, the surge in thyroid cancer prevalence and its implications on the diagnostic market
Read MoreGlobal Thrombotic Thrombocytopenic Purpura (TTP) market size is expected to reach $1.29 billion by 2030 at 4.3%, rising prevalence of cardiovascular diseases driving the market growth
Read MoreGlobal Thrombocytopenia market size is expected to reach $6.59 billion by 2030 at 7.1%, impact of rising autoimmune disease prevalence on treatment demand
Read MoreThe thrombocythaemia myelofibrosis treatment market will reach $2.5 billion by 2030 at 7.6% CAGR, driven by targeted therapies, JAK/ACVR1 inhibitors, and personalized medicine.
Read MoreExpected global throat cancer market size to grow from $3.71 billion in 2024 to $3.42 billion in 2030 at a CAGR of 8.7%, driven by rising HPV cases and tele-oncology adoption.
Read MoreGlobal Thiamine market size is expected to reach $2.3 billion by 2030 at 8.8%, segmented as by thiamine mononitrate, powder, granules, tablets
Read More